FARMINGTON, Conn., July 25, 2012 /PRNewswire-iReach/ -- Businesses looking to capture a larger slice of the lucrative mesenchymal stem cell product market need the best market research to stay ahead of the competition. Global Information Inc, in partnership with research firm BioInformant Worldwide, is pleased to present three new reports on stem cells and regenerative medicine. This new research will help businesses in the stem cell industry understand their customers by providing insight into the needs of research scientists; boost effective product development decisions; streamline marketing budgets; learn how to gain more market share; understand the key strengths and weaknesses of competitors and identify opportunities.
Mesenchymal Stem Cells – Advances & Applications
In BioInformant's recently launched market report, analysis of grant activity, publications, and patent applications reveals that Mesenchymal Stem Cell (MSC) research activity increased 112% from 2009 to 2010, and 116% from 2010 to 2011. Mesenchymal stem cells now represent fastest growing area of stem cell research. While competitors are guessing, this report divulges exactly where to focus R&D and marketing spend to create the most profitable MSC research products.
The new report identifies recent advances in MSC research applications, explores research priorities by market segment, highlights individual labs and end-users of MSC research products, explores the competitive environment for MSC research products, and provides 5-year growth and trend analysis. It is your guide for how to profit from the mesenchymal stem cell (MSC) product market – the fastest growing area of stem cell research.
To view free products samples and a full Table of Contents, visit: http://www.giiresearch.com/report/biof234291-mesenchymal-stem-cells-advances-applications.html
Complete 2012 U.S. Cord Blood Banking Industry Report
As of 2012, the cord blood banking industry is one of the fastest growing industries in the world. There were only 23 active cord blood banks as of 2005, and now just 7 years later, there are 485 worldwide. Cord blood banks now exist in nearly every developed country, as well as several developing nations. That is a 21-fold increase (2,100%) in the companies involved in the industry, over only a seven year period. This rapid market growth represents both an opportunity to profit, as well as swarming competition.
This industry report is a comprehensive road-map for operating a successful cord blood bank. It takes you from the where the industry has been, to where it is now, to where is going in the next five years. In addition, it gives you insider knowledge of how expectant parents think, so you can get there fast.
An Executive Summary of this analysis and a free sample of the full report are available at http://www.giiresearch.com/report/biof247398-complete-2012-us-cord-blood-banking-industry.html
Error-Proof Entry, Expert Positioning, and Exploding Growth in Embryonic Stem Cell Products
The potential medical advances made possible from the use of human embryonic stem cells (hESC) are huge. These stem cells are able to develop into any of over 200 different cell types. So it's no surprise that the scientific research community is enthusiastically exploring all possibilities.
And where there is significant and growing interest from scientists, there is an opportunity for a company like yours to increase revenue from supplying stem cell products. There is no doubt it's an exciting market in which to expand your product range. But with embryonic stem cells there are serious market entry barriers to consider - namely a complex intellectual property scene.
This market research report explores the complex IP landscape affecting development of human embryonic stem cell products, providing clear guidance for companies entering or already within the market, from collaborating with WARF to less costly alternatives - such as circumventing the claims, conducting research off-shore, and developing embryonic stem cell products for other species.
An Executive Summary of this analysis and a free sample of the full report are available at http://www.giiresearch.com/report/biof242923-opportunities-human-embryonic-stem-cell-product.html
About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.
Media Contact: Jeremy Palaia Global Information, Inc., 1-860-674-8796, Press@gii.co.jp
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
|SOURCE Global Information, Inc.|
Copyright©2012 PR Newswire.
All rights reserved